Skip to content

Trial of Safe Water Storage Among People Living With HIV

Randomized Controlled Trial of Safe Water Storage Among People Living With HIV

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01376336
Enrollment
1600
Registered
2011-06-20
Start date
2011-08-31
Completion date
2013-08-31
Last updated
2011-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea, HIV, Waterborne Disease

Keywords

environmental health, diarrhea, water, HIV

Brief summary

Environmental health-related pathogens include faecal-oral, diarrhoeagenic microbes that may be transmitted via drinking water and are related to sanitation and hygiene. Previous research has suggested that safeguarding household drinking water against recontamination may be a critical intervention that can reduce risks of diarrheal diseases and may be especially important for people living with HIV/AIDS (PLWHA) and other vulnerable populations (Clasen et al. 2007). The investigators propose here a randomised, controlled trial of a household safe storage container for drinking water in a well defined, HIV-impacted population in peri-urban Lusaka, Zambia. After a baseline data collection period (9 months) half of all households (150 households) will be given a safe water storage container specifically designed to prevent recontamination of water in household use. All households will be followed for an additional 9 months. Results of this study will help determine whether this promising water quality intervention can reduce diarrhoea and related outcomes in this and similar vulnerable populations.

Detailed description

Specific Aim #1: To assess environmental health-related risk and outcomes in a low income peri-urban area of Zambia with a high percentage of people living with HIV/AIDS (PLWHA) (longitudinal observational cohort study and baseline) (Year 1). We will assemble a rich dataset on environmental health-related risk factors in a well defined population, with a focus on household drinking water quality and other water, sanitation, and hygiene (WSH) exposures. Specific Aim #2: To quantify the WSH-related disease burden among PLWHA, compared with those without HIV/AIDS (individual and household level stratification) (conclusion of baseline). After nine months of data collection, we will perform an initial analysis to determine WSH-related risk by HIV status. Specific Aim #3: To assess the impact of a water quality intervention on the longitudinal prevalence of Highly Credible Gastrointestinal Illness (HCGI) among PLWHA (randomized controlled trial, year 2). We will conduct a randomised, controlled trial of a safe water storage intervention. We will assess the health impacts of this intervention, with particular focus on the high-risk groups of PLWHA and children under 5 years of age.

Interventions

DEVICESafe storage device

This device is a specially designed water storage container that is intended to reduce the likelihood of re-contamination of household stored drinking water.

Sponsors

University of Zambia
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Resident of Misisi compound, Lusaka * Willing to participate in the study * Is able to give informed consent and does so * Household has one or more children who are aged 48 months or less at the start of the trial * The household stores drinking water in the home

Exclusion criteria

* Not a resident of Misisi compound, Lusaka * Unwilling to participate in the study * Unable to give informed consent or chooses not to participate * Household does not have one or more children aged 48 months or less at the start of the trial * The household does not store drinking water in the home

Design outcomes

Primary

MeasureTime frameDescription
Self-reported diarrheal disease18 monthsSelf-reported diarrheal disease information will be collected from each study participant monthly. These data will be collected monthly with 24 hour, 48 hour, and 7-day recall. Data will be assessed at 18 months (change from baseline).

Secondary

MeasureTime frameDescription
Weight-for-age z-score18 monthsWeight-for-age z-scores will be taken for all children who are aged less than 48 months (under 5s) at the start of the trial and monthly during the trial. These data are useful in tracking short-term wasting, associated with diarrheal disease events. Data will be assessed at 18 months (change from baseline).
E. coli and total coliforms in household drinking water18 monthsMicrobiological indicators of fecal contamination of drinking water at the household level. Samples will be taken from all households monthly. Data will be assessed at 18 months (change from baseline).
Salivary antibody response18 monthsWe will collect salivary samples from all consenting individuals (an additional consent form is required) to gather information on IgG and IgA response to specific diarrheal pathogens using a multiplex assay. This measure provides useful information on both outcomes of interest (diarrheal disease) and exposure to diarrheagenic pathogens. Samples will be taken at three time points: the beginning, midpoint, and end of the trial. Data will be assessed at 18 months (change from baseline).

Countries

Zambia

Contacts

Primary ContactJoe Brown, PhD
joe.brown@lshtm.ac.uk+1 919 360 8752
Backup ContactPaul Kelly, MD
m.p.kelly@qmul.ac.uk+44 20 7882 2643

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026